AgeX Therapeutics Cash from Investing (TTM) Analysis

AgeX Therapeutics Inc (DELISTED) (AGE:DL)

11.10 -1.50 (-11.90%) USD | NYAM | Mar 26, 16:00

12.18 +1.08 (+9.73%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2023	-10.00M
June 30, 2023	-10.00M
March 31, 2023	-10.00M
December 31, 2022	0.00
September 30, 2022	0.00
June 30, 2022	0.00
March 31, 2022	0.00
December 31, 2021	0.666M
September 30, 2021	0.666M
June 30, 2021	0.654M

Date	Value
March 31, 2021	0.65M
December 31, 2020	-0.02M
September 30, 2020	-0.315M
June 30, 2020	-0.46M
March 31, 2020	-0.362M
December 31, 2019	-0.361M
September 30, 2019	-0.063M
June 30, 2019	-0.984M
March 31, 2019	-1.09M
December 31, 2018	1.327M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-10.00M

Minimum

Mar 2023

0.666M

Maximum

Sep 2021

-1.663M

Average

-0.0415M

Median

Cash from Investing (TTM) Benchmarks